All News about Structure Therapeutics Inc. - American Depositary Shares
![](https://ml.globenewswire.com/media/6c9a8c36-cd22-4d2c-8d95-9a940b2e0c1f/small/structure-inline-fullcolor-rgb-12in-300ppi-png.png)
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600d.jpg)
![](https://g.foolcdn.com/editorial/images/756110/growth-curve.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
What 6 Analyst Ratings Have To Say About Structure Therapeutics
November 15, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
4 Analysts Have This to Say About Structure Therapeutics
October 19, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/6c9a8c36-cd22-4d2c-8d95-9a940b2e0c1f/small/structure-inline-fullcolor-rgb-12in-300ppi-png.png)
![](https://g.foolcdn.com/editorial/images/753205/investing-screen-analysis-investor-growth-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/26/image30.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
October 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/749564/pharmacists-looking-at-pills-in-bottle.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/29/image9.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Intraday Session
September 29, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/749350/research-scientists-drugs-pharma-biotech.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/29/image47.jpg?width=1200&height=800&fit=crop)
Nasdaq Gains Over 1%; Nike Posts Upbeat Earnings
September 29, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://www.investors.com/wp-content/uploads/2018/03/stock-pharmaceutical-6-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/29/gpcr.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/6c9a8c36-cd22-4d2c-8d95-9a940b2e0c1f/small/structure-inline-fullcolor-rgb-12in-300ppi-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/6c9a8c36-cd22-4d2c-8d95-9a940b2e0c1f/small/structure-inline-fullcolor-rgb-12in-300ppi-png.png)
![](https://ml.globenewswire.com/media/6c9a8c36-cd22-4d2c-8d95-9a940b2e0c1f/small/structure-inline-fullcolor-rgb-12in-300ppi-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/08/08/energizer_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/08/warner_music_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/6c9a8c36-cd22-4d2c-8d95-9a940b2e0c1f/small/structure-inline-fullcolor-rgb-12in-300ppi-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2023/07/A1-071723-weightloss-CGash.jpg)
![](https://g.foolcdn.com/editorial/images/737621/scientists-examine-cell-make-up-microscope-biotech.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.